Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO 2019 Congress

AstraZeneca - Evolving the treatment practice of advanced EGFRm NSCLC

Expert opinions on hot topics: A panel discussion moderated by

Date

30 Sep 2019

Session

AstraZeneca - Evolving the treatment practice of advanced EGFRm NSCLC

Presenters

Johan Vansteenkiste

Authors

J.F. Vansteenkiste

Author affiliations

  • Department Of Respiratory Oncology, University Hospital KU Leuven, B-3000 - Leuven/BE

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Introduction

Presenter: Johan Vansteenkiste

Session: AstraZeneca - Evolving the treatment practice of advanced EGFRm NSCLC

Resources:

Webcast

Closing remarks

Presenter: Johan Vansteenkiste

Session: AstraZeneca - Evolving the treatment practice of advanced EGFRm NSCLC

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.